Enterocolitis, Necrotizing: Clinical Trials

14 trials for Enterocolitis, Necrotizing, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

14 completed. 14 Phase 2, 4 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 214Completed 14
Phase 14Completed 4
Phase 31Completed 1

Follow Enterocolitis, Necrotizing: new trials by email Literature Review of Enterocolitis, Necrotizing trials Research Report on Enterocolitis, Necrotizing

Trials (filtered) newest first · largest first

All 14 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
RIC-NEC Randomized Controlled Trial
Remote ischemic conditioning (RIC) + Standard of Care for NEC, Standard of Care for NEC - Necrotizing Enterocolitis
Phase 2CompletedThe Hospital for Sick Children862023-02-092026-11-03
Efficacy Of Oral Melatonin To Prevent Necrotizing Enterocolitis
Melatonin 6 MG, Breast Milk - Necrotizing Enterocolitis
Phase 1 / Phase 2CompletedIlocos Training and Regional Medical Center1002021-03-012024-06-20
Antibiotic "Dysbiosis" in Preterm Infants
Antibiotic, Gastric fluid, Breast milk - Enterocolitis, Necrotizing, Bacteremia
Phase 2CompletedUniversity of Florida982017-01-162024-06-05
IBP-9414 for the Prevention of Necrotizing Enterocolitis
IBP-9414, Placebo - Necrotizing Enterocolitis
Phase 2CompletedInfant Bacterial Therapeutics1202016-05-272017-12-29
Erythropoietin Protects Very Preterm Infants Against Necrotizing Enterocolitis
EPO, Normal saline - Premature Infant
Phase 2CompletedZhengzhou University12852014-01-012019-04-19
Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus
pharmacologic treatment of the PDA, no pharmacologic treatment of the PDA, NSAID - Patent Ductus Arteriosus, Surgery
Phase 2CompletedUniversity of California, San Francisco2022013-12-012018-11-30
Early Supplementation of Enteral Microlipid With and Without Fish Oil in Premature Infants With Enterostomies
Microlipid with fish oil, Microlipid - Prematurity, Intestine Perforation
Phase 2CompletedWake Forest University182012-10-012018-12-04
Enteral Administration of Docosahexaenoic Acid to Prevent Necrotizing Enterocolitis in Preterm Neonates
Docosahexaenoic acid (DHA), Placebo - Necrotizing Enterocolitis
Phase 1 / Phase 2CompletedCoordinación de Investigación en Salud, Mexico2252012-10-012021-03-24
Effect of L-arginine and Glutamine on Preterm
Glutamine, l-arginine - NEC, Sepsis
Phase 2 / Phase 3CompletedAin Shams University752011-05-012014-04-15
Severe Necrotizing Enterocolitis in Preterm Newborns <1500g Using Probiotics
probiotics Lactobacillus acidophilus boucardii - Infectious Diseases
Phase 2CompletedCoordinación de Investigación en Salud, Mexico1502010-03-012014-08-27
Enteral Granulocyte Colony Stimulating Factor and Erythropoietin Early in Life Increases Feeding Tolerance in Preterm Infants: A Randomized Controlled Trial
recombinant human G-CSF, and rhEPO, rh G-CSF, rh EPO - Feeding Intolerance, Necrotizing Enterocolitis
Phase 1 / Phase 2CompletedAin Shams University932010-01-012011-09-27
Pharmacokinetic (PK) and Safety Study of Meropenem in Young Infants With Intra-abdominal Infections
meropenem - Necrotizing Enterocolitis, Intra-abdominal Infection
Phase 1 / Phase 2CompletedThe Emmes Company, LLC2002008-06-012023-04-25
Lactulose Supplementation in Premature Infants
Lactulose, Dextrose - Necrotizing Enterocolitis, Sepsis
Phase 2CompletedBnai Zion Medical Center282005-02-012008-02-15
Comparison of 2 Different Indomethacin Dosing Protocols to Treat Infants Delivered at <28 Weeks Gestation With a Persistent Patent Ductus Arteriosus
indomethacin (two different dosing regimens) - Patent Ductus Arteriosus
Phase 2CompletedUniversity of California, San Francisco1002003-08-012008-06-04

Narrower conditions

Premature Birth (5)  ·  Ductus Arteriosus, Patent (2)  ·  Intestinal Perforation (2)  ·  Sepsis (2)  ·  Bacteremia (1)  ·  Bronchopulmonary Dysplasia (1)  ·  Communicable Diseases (1)  ·  Intraabdominal Infections (1)  ·  Leukomalacia, Periventricular (1)  ·  Short Bowel Syndrome (1)

Broader conditions

Digestive System Diseases (14)  ·  Enterocolitis (14)  ·  Gastroenteritis (14)  ·  Gastrointestinal Diseases (14)  ·  Intestinal Diseases (14)  ·  Female Urogenital Diseases and Pregnancy Complications (5)  ·  Infections (5)  ·  Obstetric Labor Complications (5)  ·  Obstetric Labor, Premature (5)  ·  Pathologic Processes (5)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Pregnancy Complications (5)  ·  Urogenital Diseases (5)  ·  Cardiovascular Diseases (3)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)

Interventions

Milk, Human (2)  ·  Ampicillin (1)  ·  Anti-Bacterial Agents (1)  ·  Anti-Inflammatory Agents, Non-Steroidal (1)  ·  Arginine (1)  ·  Biological Evolution (1)  ·  Cefotaxime (1)  ·  Docosahexaenoic Acids (1)  ·  Drainage (1)  ·  Fatty Acids, Omega-3 (1)  ·  Fish Oils (1)  ·  Gentamicins (1)  ·  Glucose (1)  ·  Glutamine (1)  ·  Indomethacin (1)

Sponsors

Ain Shams University (2)  ·  Coordinación de Investigación en Salud, Mexico (2)  ·  University of California, San Francisco (2)  ·  Bnai Zion Medical Center (1)  ·  Ilocos Training and Regional Medical Center (1)  ·  Infant Bacterial Therapeutics (1)  ·  The Emmes Company, LLC (1)  ·  The Hospital for Sick Children (1)  ·  University of Florida (1)  ·  Wake Forest University (1)  ·  Zhengzhou University (1)

Countries

United States (7)  ·  Mexico (2)  ·  Canada (1)  ·  China (1)  ·  Egypt (1)  ·  Israel (1)  ·  Philippines (1)  ·  Sweden (1)  ·  Turkey (Türkiye) (1)  ·  United Kingdom (1)

Top investigators

Josef Neu, MD (2)  ·  Agostino Pierro, OBE, MD (1)  ·  Arieh Riskin, MD (1)  ·  Changlian Zhu, PhD (1)  ·  Daisy Evangeline C Garcia, MD (1)  ·  Danny Benjamin, MD, PhD, MPH (1)  ·  GHada A. Saleh, MRCPCH (1)  ·  Mariela Bernabe-Garcia, PhD (1)  ·  Navid P Roodaki, MD (1)  ·  Qing Yang, MD, PhD (1)  ·  Ron Shaoul, MD (1)  ·  Ronald Clyman, M.D. (1)  ·  Ronald Clyman, MD (1)

Results publications

PMID 17636753, PMID 20980771, PMID 22955430, PMID 23453547, PMID 25155966, PMID 25861285, PMID 30340932, PMID 30850756, PMID 31255386, PMID 32771013, PMID 33076939, PMID 33479274, PMID 33671220, PMID 37308133, PMID 39373498

NIH funding

R21HD088005 (1)